文献速递糖尿病

新诊断2型糖尿病患者胰岛素抵抗与心衰及死亡风险增加相关:UKPDS 89

Increased Risk of Incident Heart Failure and Death Is Associated With Insulin Resistance in People With Newly Diagnosed Type 2 Diabetes: UKPDS 89.
PubMed 文献 · Diabetes Care · 2021-06-23

本研究基于UKPDS队列中5102例新诊断2型糖尿病患者(其中4344例有HOMA2-IR测量),评估胰岛素抵抗与心衰或死亡复合结局及单纯心衰的关联。中位随访16.4年期间,共发生1974例(45.4%)心衰/死亡事件。多变量分析显示,HOMA2-IR翻倍与心衰/死亡风险增加5%(RR 1.05,95%CI 1.01-1.12,P=0.0029)及心衰风险增加14%(RR 1.14,95%CI 1.02-1.27,P=0.017)独立相关。

要点

  • 新诊断2型糖尿病患者中,胰岛素抵抗程度越高,心衰或死亡风险越高。
  • HOMA2-IR翻倍与心衰/死亡风险增加5%、心衰风险增加14%独立相关。
  • 年龄、BMI、FPG、腰臀比、收缩压、LDL-C、心率等亦与心衰/死亡独立相关。

核心结论

  • 新诊断2型糖尿病患者中,胰岛素抵抗与心衰或死亡复合结局及单纯心衰风险增加独立相关。

研究设计与样本

  • 基于UKPDS前瞻性队列研究,纳入5102例新诊断2型糖尿病患者,其中4344例有HOMA2-IR测量值。
  • 采用Kaplan-Meier生存曲线和多变量生存模型分析HOMA2-IR与心衰/死亡或单纯心衰的关联,调整单变量P<0.1且多变量P<0.05的变量。

主要发现

  • 中位随访16.4年,共发生1974例(45.4%)心衰/死亡事件,包括235例首次心衰事件和1739例死亡。
  • 入组时平均(SD)年龄52.5(8.7)岁,HbA1c 7.2%(1.8%),BMI 28.8(5.5)kg/m2,HOMA2-IR中位数(四分位距)1.6(1.1-2.2)。
  • HOMA2-IR翻倍与心衰/死亡风险增加5%相关(RR 1.05,95%CI 1.01-1.12,P=0.0029)。
  • HOMA2-IR翻倍与心衰风险增加14%相关(RR 1.14,95%CI 1.02-1.27,P=0.017)。
  • 与心衰/死亡独立相关的因素还包括年龄、BMI、FPG、腰臀比、收缩压、LDL胆固醇、心率、性别、种族、吸烟状态、既往房颤和既往微量白蛋白尿。

临床怎么用

  • 对新诊断2型糖尿病患者,评估胰岛素抵抗可能有助于识别心衰和死亡高风险个体。
  • 在管理新诊断2型糖尿病时,除血糖外还应关注BMI、血压、血脂等与心衰/死亡独立相关的因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Insulin resistance (IR) may mediate heart failure (HF) development. We examined whether IR in people with newly diagnosed type 2 diabetes (T2D) increased their risk of a composite outcome of HF or death or of HF alone. RESEARCH DESIGN AND METHODS: Insulin resistance (HOMA2-IR) values for UKPDS participants were derived from paired fasting plasma glucose (FPG) and insulin measures. Kaplan-Meier survival curves and multivariable survival models were used to evaluate associations between HOMA2-IR and HF/death or HF alone. We adjusted for potential confounders by including variables with univariate associations (P < 0.1) and by requiring a multivariable P < 0.05. RESULTS: Of 5,102 UKPDS participants with newly diagnosed T2D, 4,344 had HOMA2-IR measurements. At enrollment, mean (SD) age was 52.5 (8.7) years, with HbA1c 7.2% (1.8%), and BMI 28.8 (5.5) kg/m2, and median (interquartile range) HOMA2-IR was 1.6 (1.1-2.2). HF/death occurred in 1,974 (45.4%) participants (235 first HF events, 1,739 deaths) over a median follow-up of 16.4 years. Multivariable independent associations with HF/death were older age and higher BMI, HOMA2-IR, FPG, waist-to-hip ratio, systolic blood pressure, LDL cholesterol, and heart rate as well as sex, race, smoking status, prior atrial fibrillation, and prior microalbuminuria. A doubling of HOMA2-IR was associated with a 5% greater risk of HF/death (relative risk [RR] 1.05 [95% CI 1.01-1.12], P = 0.0029) and a 14% greater risk of HF (RR 1.14, [95% CI 1.02-1.27], P = 0.017). CONCLUSIONS: Patients with newly diagnosed T2D and insulin resistance were more likely to develop HF or die than those more sensitive to insulin.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Wamil M, Coleman RL, Adler AI, et al. Increased Risk of Incident Heart Failure and Death Is Associated With Insulin Resistance in People With Newly Diagnosed Type 2 Diabetes: UKPDS 89. Diabetes Care. 2021. PMID: 34162666. doi:10.2337/dc21-0429

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。